This story is one in a series of first-person perspectives from those who are working on the frontlines to better understand, treat and prevent transmission of HIV and AIDS as well as COVID-19. You ...
Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral antiretroviral therapy (ART) in ...
People living with HIV face unique oral health challenges that require special attention and care. The virus’s impact on the immune system creates conditions that make the mouth more vulnerable to ...
More than 33 million people worldwide were living with HIV/AIDS at the end of 2008, according to the World Health Organization. Compared to nine countries in Africa, where prevalence looms between 10% ...
Once-daily oral treatments for HIV-1 infection are effective, but they can create medication compliance challenges. In an open-label phase II study, a similarly high proportion of patients randomized ...
Add Yahoo as a preferred source to see more of our stories on Google. Health Canada has approved the OraQuick HIV self-test, making it the country's first oral self-test for the virus that causes AIDS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results